Clinical Assessment and Utility of Biomarkers in Asthma-Chronic Obstructive Pulmonary Disease Overlap

Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.

Lancet. 388: 1545-1602GINA Executive and Science committee

Global strategy for asthma management and prevention.

() ()Global Initiative for Chronic Obstructive Lung Disease

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease.

() ()Milne S. Mannino D. Sin D.

Asthma-COPD overlap and chronic airflow obstruction: definitions, management, and unanswered questions.

J Allergy Clin Immunol Pract. 8: 483-495Papaiwannou A. Zarogoulidis P. Porpodis K. et al.

Asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS): current literature review.

J Thorac Dis. : S146-S151Alshabanat A. Zafari Z. Albanyan O. et al.

Asthma and COPD Overlap Syndrome (ACOS): A Systematic Review and Meta Analysis.

PLoS One. 10: e0136065Sluiter H. Koëter G. de Monchy J. et al.

The Dutch hypothesis (chronic non-specific lung disease) revisited.

Eur Respir J. 4: 479-489

The overlap syndrome of asthma and COPD: what are its features and how important is it?.

Thorax. 64: 728-735Global Initiative for Asthma (GINA)

Global Initiative for Chronic Obstructive Lung Disease (GOLD). Diagnosis and Initial Treatment of Asthma, COPD, and Asthma–COPD Overlap.

() ()Global Initiative for Chronic Obstructive Lung Disease

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease.

() ()Vanfleteren L.E. Kocks J.W. Stone I.S. et al.

Moving from the Oslerian paradigm to the post-genomic era: are asthma and COPD outdated terms?.

Thorax. 69: 72-79Sin D. Miravitlles M. Mannino D. et al.

What is asthma-COPD overlap syndrome? Towards a consensus definition from a round table discussion.

Eur Respir J. 48: 664-673Miravitlles M. Calle M. Molina J. et al.

Spanish COPD Guidelines (GesEPOC) 2021: updated pharmacological treatment of stable COPD.

Arch Bronconeumol. https://doi.org/10.1016/j.arbres.2021.03.005Yanagisawa S. Ichinose M.

Definition and diagnosis of asthma-COPD overlap (ACO).

Allergol Int. 67: 172-178Hiles S.A. Gibson P.G. McDonald V.M.

Disease burden of eosinophilic airway disease: Comparing severe asthma, COPD and asthma-COPD overlap.

Respirology. 26: 52-61

Asthma-chronic obstructive pulmonary disease overlap syndrome in Poland. Findings of an epidemiological study.

Postepy Dermatol Alergol. 31: 372-379Pleasants R.A. Ohar J.A. Croft J.B. et al.

Chronic obstructive pulmonary disease and asthma-patient characteristics and health impairment.

COPD. 11: 256-266Miravitlles M. Soriano J.B. Ancochea J. et al.

Characterisation of the overlap COPD-asthma phenotype. Focus on physical activity and health status.

Respir Med. 107: 1053-1060de Marco R. Pesce G. Marcon A. et al.

The coexistence of asthma and chronic obstructive pulmonary disease (COPD): prevalence and risk factors in young, middle-aged and elderly people from the general population.

PLoS one. 8: e62985Milanese M. Di Marco F. Corsico A.G. et al.

Asthma control in elderly asthmatics. An Italian observational study.

Respir Med. 108: 1091-1099Kauppi P. Kupiainen H. Lindqvist A. et al.

Overlap syndrome of asthma and COPD predicts low quality of life.

J Asthma. 48: 279-285Fu J.J. Gibson P.G. Simpson J.L. et al.

Longitudinal changes in clinical outcomes in older patients with asthma, COPD and asthma-COPD overlap syndrome.

Respiration. 87: 63-74Lee H. Kim S.H. Kim B.K. et al.

Characteristics of Specialist-Diagnosed Asthma-COPD Overlap in Severe Asthma: Observations from the Korean Severe Asthma Registry (KoSAR).

Allergy. 76: 223-232Park H. Lee S. Kang D. et al.

Favorable longitudinal change of lung function in patients with asthma-COPD overlap from a COPD cohort.

Respir Med. 19: 36Lange P. Çolak Y. Ingebrigtsen T.S. et al.

Long-term prognosis of asthma, chronic obstructive pulmonary disease, and asthma-chronic obstructive pulmonary disease overlap in the Copenhagen City Heart study: a prospective population-based analysis.

Lancet Respir Med. 4: 454-462Hardin M. Cho M. McDonald M.L. et al.

The clinical and genetic features of COPD-asthma overlap syndrome.

Eur Respir J. 44: 341-350Nielsen M. Bårnes C.B. Ulrik C.S.

Clinical characteristics of the asthma-COPD overlap syndrome--a systematic review.

Int J Chron Obstruct Pulmon Dis. 10: 1443-1454Kumbhare S. Pleasants R. Ohar J. et al.

Characteristics and Prevalence of Asthma/Chronic Obstructive Pulmonary Disease Overlap in the United States.

Ann Am Thorac Soc. 13: 803-810Menezes A.M.B. Montes de Oca M. Pérez-Padilla R. et al.

Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthma.

Chest. 145: 297-304Kim M. Rhee C. Kim K. et al.

Heterogeneity of asthma and COPD overlap.

Int J Chron Obstruct Pulmon Dis. 13: 1251-1260Toledo-Pons N. van Boven J.F.M. Román-Rodríguez M. et al.

ACO: Time to move from the description of different phenotypes to the treatable traits.

PLoS One. 14: e0210915Barrecheguren M. Pinto L. Mostafavi-Pour-Manshadi S. et al.

Identification and definition of asthma-COPD overlap: The CanCOLD study.

Respirology. 25: 836-849Llop-Guevara A. Chu D.K. Walker T.D. et al.

A GM-CSF/IL-33 pathway facilitates allergic airway responses to sub-threshold house dust mite exposure.

PLoS One. 9: e88714

Chronic obstructive pulmonary disease. National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care.

Thorax. 59: 1-232Plaza V. Álvarez F. Calle M. et al.

Consensus on the Asthma-COPD Overlap Syndrome (ACOS) Between the Spanish COPD Guidelines (GesEPOC) and the Spanish Guidelines on the Management of Asthma (GEMA).

Arch Bronconeumol. 53: 443-449Guerriero M. Caminati M. Viegi G. et al.

Prevalence and features of asthma-chronic obstructive pulmonary disease overlap in Northern Italy general population.

J Asthma. 56: 27-33Barrecheguren M. Román-Rodríguez M. Miravitlles M.

Is a previous diagnosis of asthma a reliable criterion for asthma-COPD overlap syndrome in a patient with COPD?.

Int J Chron Obstruct Pulmon Dis. 10: 1745-1752Hanania N.A. Celli B.R. Donohue J.F.

U. J. Martin. Bronchodilator reversibility in COPD.

Chest. 140: 1055-1063Tashkin D.P. Celli B. Decramer M. et al.

Bronchodilator responsiveness in patients with COPD.

Eur Respir J. 31: 742-750Janson C. Malinovschi A. Amaral A. et al.

Bronchodilator reversibility in asthma and COPD: findings from three large population studies.

Eur Respir J. 54https://doi.org/10.1183/13993003.00561-2019Reid D.W. Wen Y. Johns D.P. et al.

Bronchodilator reversibility, airway eosinophilia and anti-inflammatory effects of inhaled fluticasone in COPD are not related.

Respirology. 13: 799-809Calverley P.M. Burge P.S. Spencer S. et al.

Bronchodilator reversibility testing in chronic obstructive pulmonary disease.

Thorax. 58: 659-664Terl M. Sedlák V. Cap P. et al.

Asthma management: a new phenotype-based approach using presence of eosinophilia and allergy.

Allergy. 72: 1279-1287Bafadhel M. Pavord I.D. Russell R.E.K.

Eosinophils in COPD: just another biomarker?.

Lancet Respir Med. 5: 747-759Singh D. Kolsum U. Brightling C. et al.

Eosinophilic inflammation in COPD: prevalence and clinical characteristics.

Eur Respir J. 44: 1697-1700Bafadhel M. McKenna S. Terry S. et al.

Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial.

Am J Respir Crit Care Med. 186: 48-55Reddel H. Vestbo J. Agustí A. et al.

Heterogeneity within and between physician-diagnosed asthma and/or COPD: NOVELTY cohort.

Eur Respir J. https://doi.org/10.1183/13993003.03927-2020Nici L. Mammen M. Charbek E. et al.

Pharmacologic Management of Chronic Obstructive Pulmonary Disease. An Official American Thoracic Society Clinical Practice Guideline.

Am J Respir Crit Care Med. 201: e56-e69Criner G.J. Celli B.R. Singh D. et al.

Predicting response to benralizumab in chronic obstructive pulmonary disease: analyses of GALATHEA and TERRANOVA studies.

Lancet Respir Med. 8: 158-170Pavord I. Chanez P. Criner G. et al.

Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease.

N Engl J Med. 377: 1613-1629Tamada T. Sugiura H. Takahashi T. et al.

Biomarker-based detection of asthma-COPD overlap syndrome in COPD populations.

Int J Chron Obstruct Pulmon Dis. 10: 2169-2176Alcázar-Navarrete B. Ruiz Rodríguez O. Conde Baena P. et al.

Persistently elevated exhaled nitric oxide fraction is associated with increased risk of exacerbation in COPD.

Eur Respir J. 51https://doi.org/10.1183/13993003.01457-2017Kunisaki K. Rice K. Janoff E. et al.

Exhaled nitric oxide, systemic inflammation, and the spirometric response to inhaled fluticasone propionate in severe chronic obstructive pulmonary disease: a prospective study.

Ther Adv Respir Dis. 2: 55-64Zhang C. Zhang M. Wang Y. et al.

Diagnostic value of fractional exhaled nitric oxide in differentiating the asthma-COPD overlap from COPD: a systematic review and meta-analysis.

Expert Rev Respir Med. : 1-9Li M. Yang T. He R. et al.

The value of inflammatory biomarkers in differentiating asthma-COPD Overlap from COPD.

Int J Chron Obstruct Pulmon Dis. 15: 3025-3037Fingleton J. Huang K. Weatherall M. et al.

Phenotypes of symptomatic airways disease in China and New Zealand.

Eur Respir J. 50https://doi.org/10.1183/13993003.00957-2017Bousquet P.J. Castelli C. Daures J.P. et al.

Assessment of allergen sensitization in a general population-based survey (European Community Respiratory Health Survey I).

Ann Epidemiol. 20: 797-803Jamieson D.B. Matsui E.C. Belli A. et al.

Effects of allergic phenotype on respiratory symptoms and exacerbations in patients with chronic obstructive pulmonary disease.

Am J Respir Crit Care Med. 188: 187-192Putcha N. Fawzy A. Matsui E. et al.

Clinical Phenotypes of Atopy and Asthma in COPD: A Meta-analysis of SPIROMICS and COPDGene.

Chest. 158: 2333-2345Hanania N. Chipps B. Griffin N. et al.

Omalizumab effectiveness in asthma-COPD overlap: Post hoc analysis of PROSPERO.

J Allergy Clin Immunol. 143: 1629-1633.e2Shirai T. Hirai K. Gon Y. et al.

Combined Assessment of Serum Periostin and YKL-40 May Identify Asthma-COPD Overlap.

J Allergy Clin Immunol Pract. 7: 134-145.e1Kuo C.S. Pavlidis S. Loza M. et al.

T-helper cell type 2 (Th2) and non-Th2 molecular phenotypes of asthma using sputum transcriptomics in U-BIOPRED.

Eur Respir J. 49: 1602135

Precision medicine for the discovery of treatable mechanisms in severe asthma.

Allergy. 74: 1649-1659

留言 (0)

沒有登入
gif